Glaucoma News and Research

Latest Glaucoma News and Research

QLT fourth quarter revenues decrease 7.3% to $10.0 million

QLT fourth quarter revenues decrease 7.3% to $10.0 million

International conference to address pediatric congenital cataract treatment in New York City

International conference to address pediatric congenital cataract treatment in New York City

Medwell commits $2,000,000 investment in Mimetogen

Medwell commits $2,000,000 investment in Mimetogen

USPTO issues Notice of Allowance to Somaxon's Silenor patent application

USPTO issues Notice of Allowance to Somaxon's Silenor patent application

Obesity associated with decreased risk of open-angle glaucoma in women, not men

Obesity associated with decreased risk of open-angle glaucoma in women, not men

Study shows beneficial anti-fibrotic effects of Pentraxin-2 in idiopathic pulmonary fibrosis

Study shows beneficial anti-fibrotic effects of Pentraxin-2 in idiopathic pulmonary fibrosis

Study reveals beneficial anti-fibrotic effects of Pentraxin-2 in TGFβ1-induced lung disease

Study reveals beneficial anti-fibrotic effects of Pentraxin-2 in TGFβ1-induced lung disease

Promedior initiates Phase 1b clinical study of PRM-151 in patients with IPF

Promedior initiates Phase 1b clinical study of PRM-151 in patients with IPF

Clinical Data reports $2.0 million revenue for third quarter 2011

Clinical Data reports $2.0 million revenue for third quarter 2011

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

QLT's Phase II olopatadine punctal plug delivery system trial demonstrates safety in allergic conjunctivitis patients

QLT's Phase II olopatadine punctal plug delivery system trial demonstrates safety in allergic conjunctivitis patients

Two new studies report GOT may improve health outcomes of stroke patients

Two new studies report GOT may improve health outcomes of stroke patients

Vascular birthmarks can cause concern for parents: Dermatologists

Vascular birthmarks can cause concern for parents: Dermatologists

Ocular Therapeutix closes $14 million Series D financing round

Ocular Therapeutix closes $14 million Series D financing round

Harbor BioSciences announces publication of newly discovered anti-inflammatory steroids

Harbor BioSciences announces publication of newly discovered anti-inflammatory steroids

Alcon fourth quarter sales raise 5.7% to $1.81 billion in 2010

Alcon fourth quarter sales raise 5.7% to $1.81 billion in 2010

Surge in cataract surgeries fuels intraocular lens market to almost $1.4 billion

Surge in cataract surgeries fuels intraocular lens market to almost $1.4 billion

ACADIA raises $15 million through private placement

ACADIA raises $15 million through private placement

CeNeRx commences TriRima Phase II trial for treatment resistant depression

CeNeRx commences TriRima Phase II trial for treatment resistant depression

Regular eye exams are critical to prevent glaucoma

Regular eye exams are critical to prevent glaucoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.